메뉴 건너뛰기




Volumn 18, Issue 1, 2009, Pages 21-23

Euthyroid pretibial myxedema and EMO syndrome

Author keywords

EMO syndrome; Extrathyroid syndrome; Pretibial myxedema

Indexed keywords

TRIAMCINOLONE;

EID: 65249183060     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (20)

References (12)
  • 1
    • 0038454994 scopus 로고    scopus 로고
    • Anderson CK, Miller OF, 3rd. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease. J Am Acad Dermatol. 2003;48:970-2.
    • Anderson CK, Miller OF, 3rd. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease. J Am Acad Dermatol. 2003;48:970-2.
  • 2
  • 3
    • 0036169064 scopus 로고    scopus 로고
    • Dermopathy of Graves' disease (pretibial myxedema): Long-term outcome
    • Schwartz KM, Fatourechi V, Ahmed DD et al. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab. 2002;87:438-46.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 438-446
    • Schwartz, K.M.1    Fatourechi, V.2    Ahmed, D.D.3
  • 4
    • 0025033442 scopus 로고
    • Localized hyperhidrosis in pretibial myxedema
    • Gitter DG, Sato K. Localized hyperhidrosis in pretibial myxedema. J Am Acad Dermatol. 1990;23:250-4.
    • (1990) J Am Acad Dermatol , vol.23 , pp. 250-254
    • Gitter, D.G.1    Sato, K.2
  • 5
    • 27644498500 scopus 로고    scopus 로고
    • Pretibial myxedema: Pathophysiology and treatment options
    • Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6:295-309.
    • (2005) Am J Clin Dermatol , vol.6 , pp. 295-309
    • Fatourechi, V.1
  • 6
  • 8
    • 0023614470 scopus 로고
    • Euthyroid pretibial myxedema
    • Chen JJ, Ladenson PW. Euthyroid pretibial myxedema. Am J Med. 1987;82:318-20.
    • (1987) Am J Med , vol.82 , pp. 318-320
    • Chen, J.J.1    Ladenson, P.W.2
  • 10
    • 0033730232 scopus 로고    scopus 로고
    • Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): Downregulation of hyaluronic acid production by the lesional fibroblasts
    • Shinohara M, Hamasald Y, Katayama I. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts. Br J Dermatol. 2000;143:1083-6.
    • (2000) Br J Dermatol , vol.143 , pp. 1083-1086
    • Shinohara, M.1    Hamasald, Y.2    Katayama, I.3
  • 11
    • 0038578749 scopus 로고    scopus 로고
    • Successful combined surgical and octreotide treatment of severe pretibial myxoedema reviewed after 9 years
    • Felton J, Derrick EK, Price ML. Successful combined surgical and octreotide treatment of severe pretibial myxoedema reviewed after 9 years. Br J Dermatol. 2003;148:825-6.
    • (2003) Br J Dermatol , vol.148 , pp. 825-826
    • Felton, J.1    Derrick, E.K.2    Price, M.L.3
  • 12
    • 0033996653 scopus 로고    scopus 로고
    • Graves' disease presenting as localized myxoedematous infiltration in a smallpox vaccination scar
    • Pujol RM, Monmany J, Bague S et al. Graves' disease presenting as localized myxoedematous infiltration in a smallpox vaccination scar. Clin Exp Dermatol. 2000;25:132-4.
    • (2000) Clin Exp Dermatol , vol.25 , pp. 132-134
    • Pujol, R.M.1    Monmany, J.2    Bague, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.